myotonic dystrophy/utrujenost

Povezava se shrani v odložišče

Izberite vrsto razvrščanja

Stran 1 iz 21 rezultatov

Fatigue and daytime sleepiness scale in myotonic dystrophy type 1.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND Fatigue and excessive daytime sleepiness are frequent complaints in myotonic dystrophy type 1 (DM1) that often overlap. We aimed to construct a combined fatigue and daytime sleepiness rating scale for DM1 using the Rasch measurement model. METHODS Questionnaires, including the Epworth

Longitudinal in vivo muscle function analysis of the DMSXL mouse model of myotonic dystrophy type 1.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Myotonic dystrophy is the most common adult muscle dystrophy. In view of emerging therapies, which use animal models as a proof of principle, the development of reliable outcome measures for in vivo longitudinal study of mouse skeletal muscle function is becoming crucial. To satisfy this need, we

Patient Input to Inform the Development of Central Nervous System Outcome Measures in Myotonic Dystrophy.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2) are multisystem, genetic disorders caused by repeat expansions on chromosome 19 (DM1) and chromosome 3 (DM2). Although the effects of DM on the skeletal, cardiac, and smooth muscles, as well as the endocrine and central nervous

Fatigue and neuromuscular diseases.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVE To identify the role of fatigue, its evaluation and its causes in the pathophysiology context of acquired or hereditary neuromuscular diseases of the spinal anterior horn cell, peripheral nerve, neuromuscular junction and muscle. METHODS A literature review has been done on Medline with

[Successful treatment of recurrent hypoglycemia by pioglitazone in a patient with myotonic dystrophy].

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

A 20 year-old woman with myotonic dystrophy type 1 (DM1) presented with fatigue, daytime somnolence, and sudden poor responsiveness. Blood glucose was measured before and after each meal for 4 days, and hypoglycemia was confirmed twice, although neither perspiration nor palpitations occurred in the

Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVE To evaluate the potential of modafinil in reducing excessive daytime somnolence (EDS) and enhancing indexes of quality of life and mood in patients with myotonic dystrophy (DM). METHODS Forty patients with DM were randomized to receive modafinil and placebo for 14 days each, using a

[Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Myotonic dystrophy (MD) is a genetically determined disease with autosomal dominant mode of inheritance. Relatively recently, MD has been divided into two sub-types (MD1 and MD2). Clinical symptoms of MD1 result from the expansion of a (CTG)n trinucleotide of the gene coding for serine/threonine

Brain sonography insight into the midbrain in myotonic dystrophy type 2.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND The aim of this study was to analyze transcranial sonography (TCS) findings in genetically confirmed myotonic dystrophy type 2 (DM2) patients. METHODS Forty DM2 patients and 38 gender- and age-matched healthy controls (HCs) underwent TCS through the pre-auricular acoustic bone

Chronic muscle stimulation improves muscle function and reverts the abnormal surface EMG pattern in myotonic dystrophy: a pilot study.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND To date, in Myotonic Dystrophy type 1 (DM1) the rehabilitative interventions have always been aimed at muscle strengthening, increasing of fatigue resistance and improving of aerobic metabolism efficiency whereas the electrical membrane fault has always been addressed pharmacologically.

Prevalence and correlates of apathy in myotonic dystrophy type 1.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND Apathy in DM1 has long been acknowledged in clinical practice. However, a major drawback is that the concept has been only sparsely explored in previous specific studies. This study aimed to determine the prevalence of apathy in myotonic dystrophy (DM1), to compare it with

Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Myotonic dystrophy is an autosomal dominant muscular dystrophy not only associated with muscle weakness, atrophy, and myotonia but also prominent multisystem involvement. There are 2 similar, but distinct, forms of myotonic dystrophy; type 1 is caused by a CTG repeat expansion in the DMPK gene, and

Myotonic Dystrophy Type 1 Management and Therapeutics.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

UNASSIGNED Myotonic dystrophy (DM1) is the most common form of adult muscular dystrophy. It is a multisystem disorder with a complex pathophysiology. Although inheritance is autosomal dominant, disease variability is attributed to anticipation, a maternal expansion bias, variable penetrance, somatic

Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVE To assess an impact of cognitive and behavioral impairment on QoL in a larger cohort of patients with DM1. METHODS Sixty six genetically confirmed DM1 patients (22 with juvenile (jDM1) and 44 with adult form (aDM1) of the disease) were recruited. Following behavioral tests were used:

A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The symptomatic treatment of myotonia and myalgia in patients with dystrophic and non-dystrophic myotonias is often not satisfactory. Some patients anecdotally report symptoms' relief through consumption of cannabis.A combination of cannabidiol and

Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Spinal and bulbar muscular atrophy (SBMA) is characterized by progressive muscle weakness linked to a polyglutamine expansion in the androgen receptor (AR). Current evidence indicates that mutant AR causes SBMA by acting in muscle to perturb its function. However, information about how muscle

Prejšnji
1
2
Naslednji

Pridružite se naši
facebook strani

Herbal & Natural Medicine

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

Deluje v 55 jezikih
Zeliščna zdravila, podprta z znanostjo
Prepoznavanje zelišč po sliki
Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
Preberite znanstvene publikacije, povezane z vašim iskanjem
Iščite zdravilna zelišča po njihovih učinkih
Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah